-
Patients with acute coronary syndrome present one of the most common admission diagnoses in the intensive care unit. For non-cardiology intensivists, the ever-evolving treatment algorithms present a challenging body of literature on which to remain current.
-
Editor's Note: The alpha2-receptor agonist dexmedetomidine (Precedex®), introduced for perioperative and procedural sedation and other short-term applications, is approved by the FDA for use in the ICU, although the package insert emphasizes that this approved use is for not more than 24 hours.
-
While ICU clinicians understand that prognostic uncertainty is a normal part of critical care, it is unclear if surrogates hold similar views. In this study, Evans et al conducted semi-structured face-to-face interviews with 179 surrogates who had an adult patient in the ICU.
-
-
Individualization of therapy with pharmacogenetics; the rate vs rhythm debate; the FDA's Risk Evaluation and Mitigation Strategy; FDA actions.
-
-
In light of an increasing internationally mobile community, the primary care physician may see patients who have recently traveled overseas. This article highlights the manifestations of diseases that, although we may not see them often, can fool us with confusing symptoms.
-
-
Ray et al examined the computerized files of Tennessee Medicaid recipients to estimate the effects of atypical antipsychotic drugs on the risk of sudden cardiac death.
-
This meta-analysis of studies examining the efficacy of systemic corticosteroids for preventing laryngeal edema following extubation concludes that this treatment is effective. This result differs from those of several previous meta-analyses, and raises practical issues such as whether extubation should be delayed for at least 12 hours after a patient passes a spontaneous breathing trial and qualifies for extubation so that a course of steroids can be given.